News Summary

• CEO John M
• Leonard sold 26,807 shares of Intellia Therapeutics stock in a transaction that occurred on Friday, January 3rd
• The shares were sold at an average price of $12
• 18, for a total transaction of $326,509
• 26
• Following the transaction, the chief executive officer now directly owns 941,115 shares of the company’s stock, valued at approximately $11,462,780
• 70
• The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link